Myovant: Sumitomo Bid Is A Head Scratcher (NYSE:MYOV)
Jan-Otto/E+ via Getty Images Overview – Despite Heavy Losses, Myovant Stock Surged On Acquisition Bid Myovant (NYSE:MYOV) stock jumped in value last week after the company that owns 52% of the biotech – Sumitovant Biopharma […]
